Archives des News - Vesale Bioscience

17/01/2023

The European Innovation Council awards €1.8 million to Vésale Bioscience’s PhageDiag project

Namur (Belgium), 13 January 2023 Vésale Bioscience is developing innovative precision phage therapy solutions to treat bacterial infections resistant to antibiotics, and today announces that it has received a €1.8…

https://phage.health/wp-content/uploads/2023/01/eic.jpg 1920 1280 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2023/01/eic.jpg 17/01/2023 17/01/2023

30/12/2022

Vésale Bioscience for their MEDICAL FORGE Accelerator program 2023

Biosaxony, the Saxony’s Biotechnology, Medical Technology & Health Economy Cluster in Leipzig, has selected Vésale Bioscience for their MEDICAL FORGE Accelerator program 2023 (

https://phage.health/wp-content/uploads/2022/12/new-team-member-01.jpg 1920 1280 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2022/12/new-team-member-01.jpg 30/12/2022 17/01/2023

15/11/2022

Dr Vincent Grek joins the Vésale Bioscience team

CMO Dr Vincent Grek joins Vésale Bioscience as Chief Medical Officer He has a Strong Clinical Development Expertise in the biotech, nutrition and pharmaceutical industry (antibiotics, gene therapy, enzyme replacement…

https://phage.health/wp-content/uploads/2022/12/new-team-member-02.jpg 1920 1280 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2022/12/new-team-member-02.jpg 15/11/2022 14/12/2022

15/11/2022

Gunther Vanwezer joins the Vésale Bioscience team

Gunther Vanwezer joins the Vésale Bioscience team as Chief Executive Officer. He hold a Master degree in Biochemical Engineering Technology from the University of Leuven (Belgium). He has over 25…

https://phage.health/wp-content/uploads/2022/11/news-gunther-vanwezer.jpg 1920 1280 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2022/11/news-gunther-vanwezer.jpg 15/11/2022 21/12/2022

10/12/2021

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

Vésale Bioscience announces that it has been awarded the prize for most innovative start-up in life sciences in Europe during the tenth edition of BioFIT, which was held digitally from…

https://phage.health/wp-content/uploads/2021/12/Vesale-Bioscience-Named-Most-Innovative-Start-up-Life-Sciences-in-Europe-at-Tenth-Edition-of-BioFIT.jpeg 1000 480 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2021/12/Vesale-Bioscience-Named-Most-Innovative-Start-up-Life-Sciences-in-Europe-at-Tenth-Edition-of-BioFIT.jpeg 10/12/2021 10/12/2021

05/11/2021

Gérald de Patoul joins the Vésale Bioscience team

Gérald de Patoul joins the Vésale Bioscience team as Chief Business Development Officer. He co-founded of Oncomfort in May 2017 and acted for 4 years as Director and CFO, in…

https://phage.health/wp-content/uploads/2022/01/ID-picture-Gerald-de-Patoul.png 1275 1920 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2022/01/ID-picture-Gerald-de-Patoul.png 05/11/2021 05/01/2022

12/10/2021

Visit of Minister David Clarinval

Visit of Mr David Clarinval, Minister for the Middle Classes, the Self-Employed, SMEs, Agriculture, Institutional Reforms & Democratic Renewal. The minister met with Vésale Bioscience Executive Team to discuss how…

https://phage.health/wp-content/uploads/2021/09/news01.jpg 800 600 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2021/09/news01.jpg 12/10/2021 12/10/2021

07/09/2021

Philippe Ghem joins the Vésale Bioscience team

Philippe Ghem joins the Vésale Bioscience team as Chief Commercial Officer (CCO). Philippe is a commercial Engineer from the Solvay Business School (Brussels) and he brings 30 years of sales…

https://phage.health/wp-content/uploads/2021/09/news02-1.jpg 800 600 Vesale Bioscience Vesale Bioscience https://phage.health/wp-content/uploads/2021/09/news02-1.jpg 07/09/2021 11/10/2021